Trade Mark Journal No.2025/051 19 December 2025
WO0000001889636 (35,42)
Office of origin: United States of America
Date of International Registration:23 June 2025
Date of designation in the UK:
23 June 2025
The mark consists of the stacked words "BIOPHARMA", above "DEVELOPMENT AI", which is, in turn, above "BY BCG X", all to the right of a box design containing a circle and two arcs.
Protection of this mark shall give no rights to the exclusive use of the words BIOPHARMA DEVELOPMENT AI
International priority date claimed: 23 December 2024
(United States of America)
(98919023)
- Class 35
- Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; consulting services regarding cost containment in the field of clinical trials.
- Class 42
- Providing temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable generative AI software to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; providing temporary use of online non-downloadable software to automate document writing for the design, execution, and evaluation of clinical trials; providing temporary use of online non-downloadable software for business management and optimization purposes using technical data, data modelling, AI modelling, and algorithmic processes; providing technological consulting services to businesses in the field of clinical trial optimization, optimizing resource utilization, and improving success rates; providing scientific and technological consulting services for others with regard to the design, planning, management, and optimization of scientific research and clinical trials; consulting services for others in the field of design, planning, and implementation project management of clinical trials.
The Boston Consulting Group, Inc.
Representative: Michael Geller DLA Piper LLP (US), 444 West Lake Street,, Suite 900, Chicago IL 60606, UNITED STATES OF AMERICA